More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate
Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023
President Biden Revokes Trump Administration’s Workplace Diversity Training Restrictions
NAACP Lays Down First Challenge to Executive Order 13950 Prohibiting Inclusion of “Divisive” Concepts in Workplace Training Programs
HRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule
HRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model
CMS Finalizes Policy and Technical Changes to the Medicare Advantage and Part D Programs for CY 2019
Subscribe: Subscribe via RSS
Blogs
Firm/Org